Durable Medical Equipment businesses sell on documentation: clean books, transferable accreditation, and recurring revenue a buyer can verify. Owners who prepare a DME business for sale over 12 months routinely walk away with more than owners who list cold. Here is exactly what to fix, in what order.
2.5x-4.5x
Typical SDE Multiple
6-10 mo
Typical Time to Close
50%+
Recurring Revenue Target
30%
Max Referral Concentration
DME business exit planning is mostly arithmetic. Most DME businesses typically sell for 2.5 to 4.5 times Seller's Discretionary Earnings, and where you land inside that range is decided by things you can still change with a year of runway. On a business earning $600,000 in SDE, the gap between a 3.0x and a 4.0x outcome is $600,000, more than most owners save in a decade.
Every dollar of documented add-backs or margin improvement is multiplied 2.5 to 4.5 times at closing. Fixing a $50,000 problem in your books can be worth $125,000 to $225,000 in price.
Buyers underwrite the trailing 12 months hardest. Improvements you make now are fully baked into the numbers a buyer prices, improvements you make during diligence are discounted or ignored.
Accreditation, enrollment, and licensing problems take months to fix. Found early, they cost paperwork. Found by a buyer in diligence, they cost price reductions, escrows, or a dead deal.
Referral relationships take two to four quarters to diversify. You cannot fix 50% concentration in the month before you list.
The trailing 12 months before listing are also when you shift daily operations off yourself, which is the single biggest multiple driver for owner-operated DME companies.
New to DME valuations? Start with our DME business valuation guide for the full breakdown of multiples, SDE math, and what moves the range.
DME accounting is messier than most industries: rental revenue recognized over 13-month capped rental periods, oxygen rentals on 36-month cycles, resupply shipments billed on schedules, and an accounts receivable ledger full of pending claims. Buyers know this, which is why sloppy books get punished harder in DME than almost anywhere else. In your first 90 days of preparation:
SDE is your net profit plus your compensation plus legitimate one-time or discretionary expenses. Every add-back needs a document behind it. Common DME add-backs buyers will accept when they are documented:
DME has a tax trap most owners miss: depreciation recapture on the rental fleet. If you have been expensing or rapidly depreciating concentrators, beds, wheelchairs, and PAP devices for years, an asset sale can convert a large slice of your proceeds into ordinary income instead of capital gains. Sit down with your CPA 12 months out and model both an asset sale and a stock sale, because the structure that saves you taxes (usually a stock sale) is also the structure that keeps your PTAN and payer contracts intact. That overlap is unusual, in most industries sellers and buyers fight over structure, in DME the seller often has a genuine two-sided argument for selling the entity.
Also confirm your entity type early. If you are a C corporation, or an S corporation with a short S election history, the structure conversation gets more complicated and needs even more lead time.
Want a baseline before you start fixing things?
Run your numbers through BridgeBook's free valuation calculator, then run them again after cleanup and watch the range move. Requesting the free valuation report also locks a $1,000 credit toward BridgeBook's success fee, applied if BridgeBook sells your business.
The most common reason a DME business prices at 2.5x instead of 4.0x is that the business is really the owner. You hold the discharge-planner relationships, you know the billing edge cases, you approve the complex orders, and you are the person the hospital calls when a bed needs to be delivered at 7 p.m. A buyer looks at that and sees revenue that leaves when you do.
Starting 12 months out, put a customer service lead or liaison in front of every discharge planner, case manager, sleep lab, and physician office you personally handle. Do joint visits for a quarter, then step back. The goal at listing: a buyer can call your top ten referral sources (post-close, with permission) and hear names that are not yours.
If you are the only person who knows why certain HCPCS codes deny with a specific Medicaid MCO, that knowledge is an unpriced asset walking out the door at closing. Have your billing team document payer-specific rules, prior authorization workflows, same-and-similar checks, and documentation requirements (standard written orders, face-to-face notes, proof of delivery) in written SOPs. Buyers pay more for a billing operation that runs on process instead of memory.
Promote or hire a general manager or operations lead who can run intake, dispatch, inventory, and staff scheduling without you. Yes, the salary reduces SDE. It is still usually a good trade: a $90,000 manager who moves you from 3.0x to 3.75x on $500,000 of adjusted SDE adds far more to the price than the salary subtracts. Model it both ways before deciding.
Six months before listing, leave for two weeks and do not call in. Whatever breaks is your punch list. Buyers ask some version of "what happens when you are gone" in every management meeting, and "I took two weeks in March and order volume did not move" is the best possible answer.
Beyond the financials, DME diligence concentrates on four areas. Each one can move your multiple half a turn or more in either direction.
Active DMEPOS accreditation, current surety bond, clean audit history, and documentation that supports what was billed. This is pass-fail before it is a pricing input.
The split among Medicare, Medicaid, commercial, and cash retail. Diversification protects a buyer from any single fee schedule cut.
Where new orders come from, and how much depends on any single hospital system, sleep lab, or physician group.
How much of revenue recurs automatically versus having to be re-earned with every new order.
Your DMEPOS accreditation (through ACHC, The Compliance Team, HQAA, BOC, or another CMS-approved organization) and your supplier standards compliance are the foundation of the deal. Twelve months out:
Heavy Medicare concentration is common in DME and buyers price it as reimbursement risk: competitive bidding has been in a gap period for most product categories, but sophisticated buyers still model the possibility that it returns, along with routine fee schedule adjustments. A book of business spread across Medicare, Medicaid managed care, commercial plans, and a growing cash retail segment reads as much safer. If your Medicare share is above roughly 60-70%, spend the runway building commercial contracts and retail revenue (supports, aids to daily living, cash-pay PAP supplies) rather than doubling down on the categories most exposed to a single fee schedule.
Export 24 months of new orders by referral source and rank them. If one hospital system, sleep lab, or physician group generates more than 30% of new orders, that is a diligence finding, and above 40% it becomes a pricing and structure problem: buyers respond with lower offers or earnouts tied to keeping that source. Diversification is slow, relationship-driven work, which is exactly why it belongs at the start of your 12-month plan, not the end. Target two to three new consistent referral sources per quarter and track the concentration number monthly like you track revenue.
Buyers pay for revenue they do not have to re-earn. Rank your revenue by how automatically it recurs:
If resupply is under half of revenue, growing it is usually the highest-yield project of your entire preparation year: it lifts both SDE and the multiple applied to it. Also audit the rental fleet itself. A buyer will discount for concentrators and beds near end of life, so know your fleet age profile before they do.
More DME deals stall on transferability than on price. Every enrollment, accreditation, license, and payer contract has its own rules for what survives a change of ownership, and the answers differ between an asset sale and a stock sale.
In a stock sale the enrolled entity survives, so the PTAN generally continues, with CMS notified of the ownership change on the required timeline. In an asset sale the buyer typically needs its own enrollment and accreditation before it can bill, which can take months and shapes the closing calendar. Neither path is wrong, but you and your healthcare attorney should pick one deliberately 6-12 months out, because it cascades into taxes, payer contracts, and timing.
Inventory every state DME or HME license, pharmacy or oxygen permit, FDA registration for oxygen filling if you transfill, and local business licenses. Note the renewal dates and whether each one is transferable or requires a new application on change of ownership. Put this in a single spreadsheet, buyers ask for exactly this document, and producing it in a day instead of a month sets the tone for the whole diligence process.
Read the assignment clauses in your commercial payer and Medicaid managed care contracts now. Many require payer consent to assign, and some treat even a stock sale as a change of control requiring notice. State Medicaid enrollment is usually non-transferable in an asset deal. Knowing which contracts move, which need consent, and which the buyer must re-credential is the difference between a 60-day close and a 6-month close.
Experienced DME billers are scarce, respiratory therapists are scarcer, and if you sell complex rehab, your ATP-certified staff are close to irreplaceable. Buyers know all of this, so key-employee risk shows up directly in offers.
Do not announce a sale to the whole team early, uncertainty drives your best people to update their resumes. The standard play: keep the process confidential, bring one or two key leaders under NDA when a buyer reaches management meetings, and prepare a same-day communication plan for everyone else at closing. A well-run process protects the team and the deal at the same time. For more on running a confidential process end to end, see our complete guide to selling a DME business.
Here is the whole plan as one actionable sell DME business checklist, organized by how far you are from going to market.
When you are ready for the process itself, from buyer outreach through diligence and closing, read the step-by-step guide to selling your DME business.
Twelve months is the sweet spot. That gives you a full year of clean monthly financials, time to fix enrollment or accreditation issues before a buyer finds them, and room to shift referral relationships from you to your team. Six months is a workable minimum, but the shorter your runway, the more value stays on the table.
Most DME businesses typically sell for 2.5 to 4.5 times Seller's Discretionary Earnings (SDE). Companies with heavy recurring resupply revenue, a diversified payer mix, and a clean audit history command the top of the range, while businesses dependent on one referral source or one-time equipment sales land near the bottom. Larger providers with more than $1,000,000 in EBITDA are usually priced on EBITDA multiples instead.
It depends on deal structure. In a stock sale the legal entity survives, so the PTAN, DMEPOS accreditation, and most payer contracts generally stay in place, though CMS and your accrediting organization must be notified of the ownership change. In an asset sale the buyer usually needs its own enrollment and accreditation, which can take months. Decide on structure early with a healthcare attorney, because it drives both your taxes and your closing timeline.
Recurring revenue is worth more per dollar. Capped rentals, oxygen rentals, and automatic resupply programs (CPAP supplies, urological, ostomy, diabetic) give a buyer predictable cash flow, so businesses with 50% or more recurring revenue typically price at the top of the multiple range. One-time equipment sales still count, they are just harder for a buyer to underwrite.
Buyers get nervous when any single referral source, such as one hospital system or one sleep lab, generates more than 30% of new orders. Above 40%, expect a lower multiple, an earnout tied to referral retention, or both. Use your preparation window to broaden the referral base before you go to market.
Get your free valuation in about 5 minutes, then book a free 45-minute exit consultation to turn this checklist into a plan for your specific business.
BridgeBook is founder-led by Legend Atty and works on a success fee only, no retainers: 10% on the first $1,000,000, sliding to 3% above $7,000,000. Booking and attending a consultation locks a $2,500 credit toward that fee, and requesting the free valuation report adds $1,000 more, applied when BridgeBook sells your business.